Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

Partial Deficiency of Sphingosine-1-Phosphate Lyase Confers Protection in Experimental Autoimmune Encephalomyelitis

Published:2013-03-27 Issue:3 Volume:8 Page:e59630
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Billich Andreas,Baumruker Thomas,Beerli Christian,Bigaud Marc,Bruns Christian,Calzascia Thomas,Isken Andrea,Kinzel Bernd,Loetscher Erika,Metzler Barbara,Mueller Matthias,Nuesslein-Hildesheim Barbara,Kleylein-Sohn Bernadette

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Physiological and pathological actions of sphingosine 1-phosphate;T Hla;Semin Cell Dev Biol,2004

2. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling;M Maceyka;J Lipid Res,2009

3. Sphingosine 1-phosphate and cancer Nat Rev Cancer;NJ Pyne,2010

4. Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation;DJ Swan;J Cell Mol Med,2010

5. Sphingosine 1-phosphate receptor signaling;H Rosen;Annu Rev Biochem,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amelioration potential of synthetic oxime chemical cores against multiple sclerosis and Alzheimer's diseases: Evaluation in aspects of in silico and in vitro experiments;Journal of Molecular Structure;2024-12

2. Inhibiting sphingosine 1-phosphate lyase: From efficacy to mechanism;Neurobiology of Disease;2024-09

3. Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor–dependent manner;Journal of Bone and Mineral Research;2024-01-24

4. Sphingosine 1-Phosphate Lyase in the Developing and Injured Nervous System: a Dichotomy?;Molecular Neurobiology;2023-07-28

5. Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis;Pharmacology & Therapeutics;2023-06